Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 34,052 shares at $35.06 ($1.3M) on 2023-12-05, disclosed to the SEC on 2023-12-07.
Open-market sale of $1.3M RYTM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.06 | 7,026 | $246K | 19.1% |
| 2 | $35.06 | 7,026 | $246K | 19.1% |
| 3 | $40.00 | 20,000 | $800K | 61.9% |
| Total | $37.96 avg | 34,052 | $1.3M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |